Bishal Gyawali: When a new trial is published or presented, the first thing you do should not be tweet “congratulations” at the author…

Bishal Gyawali, an Associate Professor at the Division of Cancer Care and Epidemiology at Queen’s University, Kingston, Canada, wrote on Twitter/X.

“Don’t know who needs to hear this but when a new trial is published or presented, the first thing you do should not be tweet “congratulations“ at the author or say “great news for the patients”. The first thing you do should be to actually read the paper and decide whether you agree with the choice of control arm or the trial methods.”

Source: Bishal Gyawali/Twitter